The developing hypopharyngeal microbiota in early life by Mortensen, Martin Steen et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
The developing hypopharyngeal microbiota in early life
Mortensen, Martin Steen; Brejnrod, Asker Daniel; Roggenbuck, Michael; Abu Al-Soud,
Waleed; Balle, Christina; Krogfelt, Karen Angeliki; Stokholm, Jakob; Thorsen, Jonathan;
Waage, Johannes Eichler; Rasmussen, Morten Arendt; Bisgaard, Hans; Sørensen, Søren
Johannes
Published in:
Microbiome
DOI:
10.1186/s40168-016-0215-9
Publication date:
2016
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Mortensen, M. S., Brejnrod, A. D., Roggenbuck, M., Abu Al-Soud, W., Balle, C., Krogfelt, K. A., ... Sørensen, S.
J. (2016). The developing hypopharyngeal microbiota in early life. Microbiome, 4, [70].
https://doi.org/10.1186/s40168-016-0215-9
Download date: 03. Feb. 2020
RESEARCH Open Access
The developing hypopharyngeal microbiota
in early life
Martin Steen Mortensen1, Asker Daniel Brejnrod1, Michael Roggenbuck1, Waleed Abu Al-Soud1, Christina Balle1,
Karen Angeliki Krogfelt3, Jakob Stokholm2, Jonathan Thorsen2, Johannes Waage2, Morten Arendt Rasmussen2,4,
Hans Bisgaard2 and Søren Johannes Sørensen1*
Abstract
Background: The airways of healthy humans harbor a distinct microbial community. Perturbations in the microbial
community have been associated with disease, yet little is known about the formation and development of a
healthy airway microbiota in early life. Our goal was to understand the establishment of the airway microbiota
within the first 3 months of life.
We investigated the hypopharyngeal microbiota in the unselected COPSAC2010 cohort of 700 infants, using 16S
rRNA gene sequencing of hypopharyngeal aspirates from 1 week, 1 month, and 3 months of age.
Results: Our analysis shows that majority of the hypopharyngeal microbiota of healthy infants belong to each
individual’s core microbiota and we demonstrate five distinct community pneumotypes. Four of these
pneumotypes are dominated by the genera Staphylococcus, Streptococcus, Moraxella, and Corynebacterium,
respectively. Furthermore, we show temporal pneumotype changes suggesting a rapid development towards
maturation of the hypopharyngeal microbiota and a significant effect from older siblings. Despite an overall
common trajectory towards maturation, individual infants’ microbiota are more similar to their own, than to
others, over time.
Conclusions: Our findings demonstrate a consolidation of the population of indigenous bacteria in healthy airways
and indicate distinct trajectories in the early development of the hypopharyngeal microbiota.
Keywords: Airway microbiome, Infant microbiome, Microbiome development
Background
No surfaces on the human body escape colonization by
microbes; this is particularly true for the large surface
area of the gut.
The human gut microbiota has been extensively studied
[1]. It is shown that the gut is initially, in newborn infants,
colonized by facultative anaerobe skin bacteria, followed
by better adapted obligate anaerobe bacteria, when a suffi-
ciently anaerobic environment has formed [2, 3]. During
the first years of life, the gut microbiota adapts to chan-
ging diet and is over time shaped into specific enterotypes,
each representing a more or less well-defined microbiota
composition [4]. The gut microbiota has been shown to
influence maturation of the immune system and the de-
velopment of various immune-mediated diseases [5–8].
The human lungs have a larger surface area than the
gut [9, 10] and similarly provide intimate contact with
the host immune system. However, healthy lungs have
traditionally been considered sterile and only colonized
by bacteria during infections. In addition, the lower
airways are difficult to access, which makes sampling
invasive and uncomfortable. Recent studies have how-
ever found correlations between specific compositions of
the airway microbiota and diseases such as chronic
obstructive pulmonary disease, cystic fibrosis and asthma
[11–13]. Studies with low numbers of healthy adults
have overcome the inherent difficulties in sampling the
lower airways. In these studies, lung-specific bacteria
have been identified in bronchoaveolar lavage samples
by comparison to multiple sites along the upper and
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lower airways [14]. Others have shown that there is a
microbiological continuity within the airways of
healthy adults, where the lower airways are distinct
from the upper airways, but contains many of the
same bacteria [15].
Studies of the early upper airway microbiota in infants
have linked the early microbiota to disease development
later in life. We have previously demonstrated that
indeed 22% of neonates were asymptomatically carrying
Haemophilus influenzae, Streptococcus pneumoniae, and
Moraxella catarrhalis. These children exhibited four- to
fivefold increased risk of developing asthma later in child-
hood [16]. Teo et al. studied the infant nasopharyngeal
microbiota and found that certain bacteria correlated to
acute respiratory infections and the risk of allergic
sensitization and chronic wheeze [17].
More knowledge on the development of the airway
microbiota in early life is a fundamental necessity for
understanding the interactions between the microbiota
and the developing immune system, which are expected
to impact later health [18].
The present study is based on the prospective
Copenhagen Prospective Studies on Asthma in Childhood
2010 (COPSAC2010) mother-child birth cohort [19]. Here,
the hypopharyngeal microbiota of healthy infants was
sampled by aspirations at 1 week, 1 month, and 3 months
of age. We explore the hypopharyngeal microbiota devel-
opment to determine if distinct microbial community
types exist during early life.
Results
Sample population
In this study, we included 1788 hypopharyngeal samples
collected from 695 infants at 1 week, 1 month, and
3 months after birth; samples from all time-points were
included from 438 of the infants. The anthropometric
and seasonal information about the infants in this study,
as well as data on antibiotic use and diet, is shown in
Table 1. Additionally, we have included 32 DNA extrac-
tion negative controls in our analysis.
Low biomass samples
To ensure that our analyses were not confounded by
spurious results from low biomass samples, we first ana-
lyzed the alpha diversity of negative control samples that
produced sequencing reads and hypopharyngeal samples
(Additional file 1: Figure S1). The DNA extraction negative
controls had significantly lower observed richness than all
hypopharyngeal samples, with exception of the extremely
low DNA group (analysis of variance (ANOVA), P = 0.64),
and evenness were significantly higher in the DNA extrac-
tion negative controls compared to the hypopharyngeal
samples (ANOVA, P < 10−7). Having confirmed that our
samples differed from the controls, we created a heatmap
of the 25 most abundant OTUs, with the samples clustered
by their Euclidian distances (Fig. 5). The samples did not
show any clustering by extracted DNA concentration;
therefore, we chose to include all samples.
Composition of hypopharyngeal microbiota over time
The most frequent phyla were Firmicutes (61% of reads),
Proteobacteria (30%), Actinobacteria (6%), and Bacteroi-
detes (2%) (Additional file 2: Figure S2). We observed a
temporal increasing alpha diversity (Shannon's diversity
index (SDI): mean 1.09, 1.26, and 1.44, ANOVA P < 10−5
and P < 10−6, respectively; Observed richness: mean 55.2,
77.1 and 80.2, ANOVA P < 10−7 and P = 0.17, respectively)
and seasonal variation; Observed richness was high during
spring (March, April, and June) and low during summer
(June, July, and August) (ANOVA P = 0.006, 10−5, and 0.02,
respectively), SDI tended to be low in summer and high in
winter and spring but not significantly so (Additional file 1:
Table S1). There was a change in the microbiota compos-
ition between time-points: The genus Streptococcus almost
doubled between 1 week and 1 month and then maintained
that abundance at 3 months (17, 31, and 29% of reads, re-
spectively; ANOVA P < 10−7 and P = 0.5, for the two time
spans). Staphylococcus genus dominated at 1 week but de-
creased more than 50% between each of the following
time-points (49, 22, and 10%; ANOVA P < 10−7 between all
time-points). The abundance of Moraxella genus increased
between each time-point, from 9% at 1 week, to 13%
at 1 month, and to 23% at 3 months (ANOVA P < 0.01
and P < 10−7, for the two time spans respectively).
Table 1 Characteristics of the study population (n = 695 infants)
Characteristic Summary
statistic
Anthropometrics
Boys, n(%) 356 (51%)
Gestational age <36 weeks, n(%) 20 (3%)
C-section, n(%) 150 (22%)
Mother asthmatic, n(%) 181 (26%)
Mother antibiotic in third trimester, n(%) 31 (4%)
Siblings, n(%) 392 (56%)
Season of birth
Spring, n(%) 184 (26%)
Summer, n(%) 149 (21%)
Fall, n(%) 148 (21%)
Winter, n(%) 2 (31%)
Clinical information 1 week 1 month 3 months
Samples, n 544 621 623
Antibiotic used, n(%) 11 (2%) 23 (4%) 34 (5%)
Only breastfed, n(%) 477 (88%) 473 (76%) 394 (63%)
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Core microbiota in each infant
We investigated the stability of the microbiota compos-
ition and the abundance of OTUs present in infants at
all time-points (437 infants, Additional file 1: Table S2)
to determine which proportion of the infants hypophar-
yngeal microbiota that were from continuously present
OTUs, expected colonizers, and which were transient
OTUs, that were not persistent members of the infants
microbiota. We defined an infant’s individual core
microbiota as the OTUs present in all three samples
from that infant. Each infant’s core microbiota consisted
of 1–17 OTUs, most commonly Streptococcus_OTU4,
with the five most abundant genera dominating the ten
most common OTUs (Additional file 1: Table S3). Com-
paring the median abundance of the core microbiota at
each time-point (1 week : 90%, 1 month : 81%, and
3 months : 63%), we found a significant decrease in the
median core microbiota (Wilcoxon P < 0.001), reflecting
increased diversity as the hypopharyngeal microbiota
develops. However, OTUs already present at 1 week rep-
resented 63% of the microbiota abundance at 3 months,
indicating an early establishment of a permanent resi-
dent hypopharyngeal microbiota.
Characterization of pneumotypes
Having shown that bacteria with a continuous presence
represent a large fraction of the hypopharyngeal micro-
biota we wanted to investigate how well the children
cluster based on their hypopharyngeal microbiota.
Distance-based clustering revealed that the samples were
optimally described by five clusters, as shown in Fig. 1,
henceforth referred to as pneumotype I to V, based on
the average silhouette width metric. We confirmed that
no other five-cluster grouping had lower within cluster
distances using a permutation test (P < 10−6), thus con-
firming that our clustering is the optimal representation
of five clusters.
Characterizing the main microbial constituents of each
pneumotype using the indicator species approach [20],
we found clear indicator OTUs from the genera
Staphylococcus (pneumotype I), Streptococcus (pneumo-
type II), Moraxella (pneumotype III), and Corynebacterium
(pneumotype IV) (Fig. 2; Additional file 1: Table S5). In
addition to differences in main microbial constituents,
pneumotypes I and III had a significantly lower SDI
(ANOVA, P < 10−15), while the observed richness was
significantly higher for pneumotypes II and V (ANOVA,
P < 10−15).
The effects of clinical exposures on the pneumotypes
were compared at each time-point separately. At any
time-point, more of the infants with pneumotype III and
V had siblings (65.2–80.9%), and at 3 months signifi-
cantly fewer of the infants with pneumotype I had
siblings (26.4%). The proportion of infants delivered by
caesarean section was significantly different between the
pneumotypes at 1 month, pneumotype III had a lower
proportion of infants born by caesarean section (12.4%),
while pneumotype IV had the highest (34.0%). The pro-
portions of infants born by caesarean section were very
different in the 1-week samples, and following a similar
pattern at the 3-month time-point, these differences
were not significant. The pneumotypes did not seem to
have a consistent proportion of infants having received
antibiotic treatment at any point before sampling. At
1 month, pneumotype IV did have a significantly higher
proportion of infants that had received antibiotic treat-
ment. Similarly, exclusively breastfeeding was not con-
sistently correlated with the pneumotypes over time, but
at 1 month a significantly lower proportion of the in-
fants with pneumotype I or II were still exclusively
breastfed. All data are shown in Table 2.
Time dependency of pneumotypes
There was a significant change in the distribution of
samples in the five pneumotypes over time (χ2 test,
P < 10−15; Fig. 3). The number of infants with pneumo-
type I decreased while pneumotypes II, III, and V became
more abundant. Despite these large-scale changes over
time, the pneumotypes were correlated over the two
time spans, 1 week vs. 1 month and 1 month vs.
3 months (P = 0.004 and P < 10−6, respectively). Addition-
ally, finding the same pneumotype at 1 month and
3 months (34% of infants) was more likely than at 1 week
and 1 month (28%) (χ2 test, P = 0.03). To compare how the
pneumotypes correlated from 1 week to 3 months, we
analyzed samples from the 437 infants with samples
from all time-points (Additional file 1: Table S2). Of
these infants, the proportion maintaining the same
pneumotype at all time-points (9.4%) was significantly
higher than random (χ2 test, P < 0.003). This was also
true when testing each pneumotype separately, except
for the less well-defined pneumotype IV (Additional
file 1: Table S7).
The changes in pneumotypes over time show that the
maturation of the hypopharyngeal microbiota follows a
trajectory, while still being partially dependent on the
initial colonization found at 1 week.
The infants with stable pneumotypes had significantly
higher core microbiota abundance than infants with
changing pneumotypes (ANOVA, P = 0.006). This
difference in abundance of core microbiota between the
two groups increased over time (Fig. 4, Additional file 1:
Table S8).
Comparison of distance within and between infants
To confirm that this maturation of the microbiota was
not solely a time-dependent change, we analyzed the ra-
tio of the weighted UniFrac distance from each infant’s
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1-week sample to 1-month sample and the distance to
other infants’ 1-month samples and similarly from
1 month to 3 months. Over the two time spans, the
median ratios were 0.93 and 0.87, respectively.
These were confirmed to be significantly different
from 1.0 by permutations of which column repre-
sented the infants’ own samples in the distance
matrix (both P < 0.0001). When comparing 1-week
samples to 3-month samples, the median ratio was
0.98 (P = 0.07), meaning that the distances to the in-
fants’ own samples were not significantly lower than
the distance to other infants’ samples.
Based on these distances, the development of each
infant’s 1-week microbiota could not be linked
directly to the microbiota at 3 months; but when
including the 1-month microbiota, there was a trace-
able development from 1-week microbiota to 3-month
microbiota.
Discussion
We here present the first extensive study of the early
hypopharyngeal microbiota in 695 healthy infants at
1 week, 1 month, and 3 months of age.
We show that 63% of the hypopharyngeal micro-
biota at 3 months is from OTUs present already at
1 week. This strongly indicates that the airways of
healthy individuals are colonized by bacteria and that
very early colonization is important for the formation
of the microbiota later in life. At the same time, the
pattern of initial colonization by Staphylococcus,
followed by better adapted colonizers (e.g., Streptococ-
cus, Moraxella), is similar to how the gut microbiota
is colonized in early life [2]. Studies of the airway
microbiota in infants have mainly investigated the
nasopharyngeal region. Biesbroek et al. have presented
two studies of the nasopharyngeal microbiota from
6 weeks to 6 or 24 months in which they have found
1 week 1 month 3 months
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Fig. 1 Pneumotype clusters separated in NMDS plots using 4 axes. Microbial clustering on the basis of weighted UniFrac distances, visualized by
non-metric multidimensional scaling (NMDS, stress = 0.073), with ellipses encircling 75% of samples from each pneumotype. a Pneumotypes I, II,
and III are separated on NMDS axes 1 and 2, with pneumotypes IV and V overlapping in the center of the plot. b On axes 3 and 4, pneumotype
IV separates from the other pneumotypes. Axes’ minimum and maximum limits were fixed to exclude six outlying samples; the coordinates of
these samples can be found in Additional file 1: Table S4
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early presence of Staphylococcus, followed by later
dominance of Moraxella and Corynebacterium [21, 22].
We found Staphylococcus dominated at 1 week but rapidly
declined over the next 3 months, indicating a general
trend that it is an initial colonizer of the upper
airways, which only has a significant presence within
the first 6 months of life. Furthermore, the high
prevalence of Streptococcus and Moraxella is similar
to results from studies of the nasal swabs collected in
Switzerland [23].
We present five pneumotypes, which are defined
using a robust methodology inspired by the approach
used to identify gut enterotypes [4] and character-
ized them with regard to composition, indicator
OTUs, and development over time. We found that
9.4% of the infants had the same pneumotype at all
three time-points. Bosch et al. found similar data
studying nasal swabs collected within the first
6 months of life, describing a cluttered pattern that,
when studied in depth, present clear microbial suc-
cession patterns [24].
The presence of pneumotypes and their temporal non-
random changes indicates that non-random drivers
shape the hypopharyngeal microbiota. We found that
having siblings had the most significant impact on the
hypopharyngeal microbiota, with only children more
likely to present pneumotype I at 3 months of age.
Furthermore, we found that delivery method, antibiotic
use, and breastfeeding were significantly correlated with
the microbiota at 1 month, but not at 1 week. This indi-
cates that these variables do not change the early domin-
ance by Staphylococcus, while still being important for
the development of the hypopharyngeal microbiota
when Staphylococcus no longer dominates.
Through studies of fecal samples as indicators of gut
microbiota in early life, the gut microbiota was shown to
affect development of the immune and lifestyle disorders
such as obesity and diabetes [8, 25–27]. Similarly, studies of
the upper airway microbiota, as an indicator of the lower
airway microbiota, show correlation with disease develop-
ment later in life [17, 28]. The vast surface areas of the air-
ways provide intimate contact between microbiota and the
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Fig. 2 Abundance of dominant genera shows the difference between pneumotypes. Bar plot showing the abundance indicator genera in each
sample, separated by time. a One-week samples. b One-month samples. c Three-months samples. The samples are sorted by pneumotype and
within the pneumotype, by the abundance of the pneumotypes indicator genus. Pneumotype have been abbreviated as PT in this figure
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immune system. Therefore, the early hypopharyngeal
microbiota may similarly be studied as surrogate for the
lower airway microbiota’s immune modulation ability, e.g.,
leading to increased airway inflammation, which has been
indicated using murine models [18] and observed in chil-
dren linking early life bacterial colonization to asthma [16].
Published data have shown that an infant’s nasopha-
ryngeal microbiota dissimilarity increases over time
while still having lower within-subject, than between-
subject, dissimilarity [23]. We identified a similar pat-
tern, the weighted UniFrac distances suggested that the
bacterial community present at 1 week might not be
predictive of the microbiota at 3 months; however, we
could follow the development when including the 1-
month sample. This indicates that the time span be-
tween 1 week and 3 months may be too long when
analyzing the initial colonization of the hypopharynx,
and that it would be prudent to increase the sampling
frequency in future studies.
To appreciate the results of this study, the limitations
of our study should be taken into account. The cohort
we have studied was established in order to study more
than just the development of the hypopharyngeal micro-
biota. Therefore, the cohort did not have as strict exclu-
sion criteria as other studies, i.e. we have included
infants born earlier than week 36 of gestation (3%) and
did not excluded infants if they had been treated with
antibiotics prior to sampling (5%). The cohort is
Table 2 Characterization of pneumotypes
Pneumotype I Pneumotype II Pneumotype III Pneumotype IV Pneumotype V
One week, n One week, n 87 51 24 85
Age at sampling in days, mean ± sd 8.1 ± 2.7 8.0 ± 3.7 7.6 ± 2.8 7.8 ± 3.0 8.0 ± 3.1
SDI, mean ± sd 0.83 ± 0.51 1.31 ± 0.42 0.78 ± 0.49 1.57 ± 0.63 1.74 ± 0.46
Observed Richness, mean ± sd 21.5 ± 11.4 24.3 ± 8.2 19.0 ± 8.0 23.4 ± 11.5 25.8 ± 9.6
Exclusively breastfed, n(%) 266 (90.8%) 72 (83.7%) 47 (92.2%) 20 (83.3%) 72 (86.7%)
Any antibiotic, n(%) 3 (1.0%) 2 (2.4%) 1 (2.0%) 1 (4.2%) 4 (4.9%)
Caesarean section, n(%) 66 (22.2%) 13 (14.9%) 8 (15.7%) 1 (4.2%) 21 (24.7%)
Siblings, n(%) 163 (55.1%) 47 (54.0%) 39 (76.5%) 12 (50.0%) 60 (70.6%)
Mother asthmatic, n(%) 76 (25.7%) 20 (23.0%) 17 (33.3%) 6 (25.0%) 25 (29.4%)
Male, n(%) 152 (51.2%) 47 (54.0%) 27 (52.9%) 13 (54.2%) 35 (41.2%)
One month, n 137 211 89 53 131
Age at sampling in days, mean ± sd 31.3 ± 4.7 32.6 ± 5.3 32.2 ± 5.8 31.1 ± 3.7 32.5 ± 5.6
SDI, mean ± sd 0.87 ± 0.55 1.41 ± 0.48 0.77 ± 0.42 1.40 ± 0.48 1.64 ± 0.43
Observed Richness, mean ± sd 22.5 ± 13.2 29.1 ± 10.8 19.1 ± 7.2 22.3 ± 8.8 30.5 ± 14.5
Exclusively breastfed, n(%) 96 (70.1%) 152 (72.7%) 76 (85.4%) 41 (78.8%) 108 (83.1%)
Any antibiotic, n(%) 3 (2.2%) 8 (3.8%) 3 (3.5%) 6 (11.8%) 3, (2.3%)
Caesarean section, n(%) 41 (29.9%) 47 (22.3%) 11 (12.4%) 18 (34.0%) 20 (15.3%)
Siblings, n(%) 68 (49.6%) 98 (46.4%) 72 (80.9%) 23 (43.4%) 99 (76.2%)
Mother asthmatic, n(%) 37 (27.2%) 59 (28.1%) 26 (29.5%) 14 (26.4%) 27 (20.6%)
Male, n(%) 69 (50.4%) 114 (54.0%) 46 (51.7%) 30 (56.6%) 61 (46.6%)
Three months Samples, n 54 196 165 30 178
Age at sampling in days, mean ± sd 93.0 ± 5.9 92.9 ± 6.3 92.6 ± 7.1 91.7 ± 4.6 93.9 ± 6.6
SDI, mean ± sd 1.24 ± 0.53 1.47 ± 0.50 0.97 ± 0.51 1.72 ± 0.43 1.80 ± 0.47
Observed Richness, mean ± sd 31.6 ± 10.1 34.4 ± 12.1 24.39 ± 10.5 28.7 ± 11.3 35.0 ± 13.4
Exclusively breastfed, n(%) 34 (64.2%) 65.5% (127) 66.2% (102) 20 (66.7%) 111 (65.7%)
Any antibiotic, n(%) 2 (3.8%) 13 (6.8%) 5 (3.3%) 0 (0.0%) 15 (8.9%)
Caesarean section, n(%) 13 (24.1%) 46 (23.5%) 28 (17.0%) 9 (30.0%) 34 (19.1%)
Siblings, n(%) 14 (26.4%) 85 (43.4%) 126 (76.4%) 13 (43.3%) 116 (65.2%)
Mother asthmatic, n(%) 14 (25.9%) 47 (24.1%) 46 (28.0%) 5 (16.7%) 51 (28.8%)
Male, n(%) 29 (53.7%) 99 (50.5%) 86 (52.1%) 9 (30.0%) 92 (51.7%)
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generally representative for Denmark, with a slight skew
towards maternal asthma and atopic disease, as well as
socioeconomic factors (employment and household in-
come) [19]. Furthermore, we acknowledge that reported
associations to the clinical exposures are unadjusted,
and future work will be needed to identify interactions
between various influences on microbiota. This study
was designed for classical culturing and identification of
microbiota, without the rigorous focus on negative
controls in all steps of the process we lack negative
controls taken during sampling. Lastly, we have shown
that samples with the lowest biomass did not have a
higher richness than our DNA extraction negative
controls and with SDI different from, but close to,
the DNA extraction negative controls.
The strength of this study is the size of the cohort
studied, with samples from 695 infants and most
sampled at all time-points. Furthermore, the extensive
focus on confirmation and verification has provided
extensive and high quality metadata.
Conclusions
In summary, we found that healthy infant airways are col-
onized by a core microbiota, which contains the majority
of the hypopharyngeal microbiota. Our findings demon-
strate that there is an overall time-dependent development
of the hypopharyngeal microbiota, i.e., the decrease of
Staphylococcus and increase of genera normally present in
the airways, e.g., Streptococcus, Moraxella, and Haemophi-
lus [11, 17, 29], leading to the formation of a microbiota
community which can be separated into specific pneumo-
types. Furthermore, we found that having siblings had the
most significant impact on which pneumotype an infant
would present, as it was seen that infants with siblings
were less likely to harbor a hypopharyngeal microbiota
dominated by Staphylococcus.
Our findings indicate that formation and development
patterns of the hypopharyngeal microbiota share similar-
ities with gut microbiota. We report that the very early
colonization of the hypopharynx is of important for
hypopharyngeal microbiota development. Furthermore,
PT I
PT II
PT III
PT IV
PT V
PT I
PT II
PT III
PT IV
PT V
PT I
PT II
PT III
PT IV
PT V
1 week 1 month 3 months
Fig. 3 Dynamics of the infants’ pneumotype shown by an alluvial plot. Alluvial plot showing which pneumotype each infant presents over time,
including the 438 infants with three samples (Additional file 1: Table S6). Each infant is represented by a line connecting their pneumotype at
1 week, through their pneumotype at 1 month, to their pneumotype at 3 months. The first part of the lines, from 1 week to 1 month, colored by
their pneumotype at 1 week, and the second part of the lines, from 1 month to 3 months, colored by their pneumotype at 1 month. Pneumotype
have been abbreviated as PT in this figure
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as others have shown that airway microbiota compos-
ition is related to development of asthmatic disease, in-
dicating that the very early microbiota might influence
the risk of asthma later in life.
Methods
Study population and sample collection
COPSAC2010 is an ongoing Danish cohort study of
700 unselected children and their families followed
prospectively from pregnancy week 24 in a protocol
designed from the first COPSAC birth cohort (COP-
SAC2000) [30]. Exclusion criteria were gestational age
below week 26, maternal daily intake of more than
600 IU vitamin D during pregnancy, or having any
endocrine, heart, or kidney disorders [19].
The hypopharyngeal microbiota was sampled from
healthy infants during clinical visits at 1 week, 1 month,
and 3 months of age. Hypopharyngeal aspirates were
collected with a soft suction catheter passed through the
nose into the hypopharynx as previously described in
detail [19]. If the infants suffered from acute airway
symptoms during their clinical visit, or if their parents
reported wheezing or coughing in the days before or
after sampling, the samples were classified as “acute”
and excluded from this study. Antibiotic use was recorded
as a categorical variable (yes/no) of whether the infant had
received antibiotics at birth or at any other time before
sampling. Only breastfeeding was recorded as a categor-
ical variable (yes/no) of whether the infant had been intro-
duced to any other food before sampling. In total 1988
samples were collected and initially included in the study
(Additional file 1: Table S2). The aspirates were diluted in
1-ml sterile 0.9% NaCl and transported to the microbio-
logical laboratory at Statens Serum Institut, Copenhagen,
Denmark. Here, the samples were distributed into 150-μl
aliquots and stored at −80 °C.
DNA extraction and 16S amplicon sequencing
Genomic DNA was extracted using the PowerMag® Soil
DNA Isolation Kit optimized for epMotion® (MO-BIO
Laboratories, Inc., Carlsberg, CA, USA) using the epMo-
tion® robotic platform model (Eppendorf ) under manu-
facturer’s protocol. One hundred fifty microliters was
used from each sample. At least one DNA extraction
negative controls was included in each 96-well plate, by
adding 150 μl of molecular grade water (Sigma-Aldrich,
Merck, Germany) instead of a sample. DNA concentra-
tions were determined using the Quant-iT™ PicoGreen®
quantification system (Life Technologies, CA, US).
Extracted DNA was stored at −20 °C.
The 16S rRNA gene amplification procedure was
divided into two PCR steps: first, amplification of the
hypervariable V4 region of the 16S rRNA gene, using
the modified broad range primers 515F (5′-GTGC
CAGCMGCCGCGGTAA-3′) and 806R (5′-GGAC-
TACHVGGGTWTCTAAT-3′) [31–33], then sequencing
primers and adaptors were added to the amplicon prod-
ucts in the second PCR step. The amplification products
were then purified with Agencourt AMPure XP Beads
(Beckman Coulter Genomics, MA, USA), pooled
equimolar, concentrated using the DNA Clean & Con-
centrator™-5 Kit (Zymo Research, Irvine, CA, USA), and
the concentrations were then determined using the
Quant-iT™ High-Sensitivity DNA Assay Kit (Life Tech-
nologies). Paired-end sequencing, of up to 192 samples,
was performed on the Illumina MiSeq System (Illumina
Inc., CA, USA), including 1.0% PhiX as internal control.
All reagents used were from the MiSeq Reagent Kits v2
(Illumina Inc., CA, USA). All details have been included
in Additional file 1: Method S1.
Bioinformatics analysis
Fastq files demultiplexed by the MiSeq Controller Soft-
ware were trimmed for amplification primers, diversity
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Fig. 4 The core microbiota is more abundant in infants having one
pneumotype continuously. Percentage of reads from the core
microbiota over time, separated by whether or not the sample
belongs to an infant, which have one pneumotype continuously.
There is an increasing difference in core microbiota abundance
between the two groups over time (Additional file 1: Table S8),
being significantly different at 3 months (Wilcoxon rank sum
test, P = 0.001)
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spacers, and sequencing adapters (biopieces [34]),
mate-paired and quality filtered (usearch v7.0.1090
[35], parameter: −maxee 0.5). UPARSE [36] was used
for OTU clustering as recommended (97% similarity cut
off), and for removing singletons after dereplication.
Chimera checking was performed with usearch
against the gold database [37] as recommended. Rep-
resentative sequences were classified (Mothur v.1.25.0
[38], wang() function at 0.8 confidence threshold).
Qiime wrappers for PyNAST [39], FastTree [40], and
filter_alignment.py [41] were used to construct a
phylogenetic tree. Alignments were built against the
2011 version of Greengenes [42] (parameters: –allo-
wed_gap_frac 0.999999 and –threshold 3.0).
The rarefaction curves (Additional file 1: Figure S3)
show the observed richness and the SDI as functions of
count of sequences. SDI curves reach asymptotes with
1000 sequences; based on this, all samples with less than
2000 sequences were excluded. Additionally, two sam-
ples were excluded because of unusually high diversity;
their SDI was more than 5 standard deviations higher
than the mean. We included 1788 samples containing an
average of 52,749 sequences per sample, representing
3715 distinct OTUs. To avoid bias due to sampling
depth, we removed the difference by randomly subsamp-
ling the OTU table at even sequencing depth of 2000
observations. All further post-analyses were based on
the even OTU table.
Low biomass samples
For comparison of control samples (mock communities
and DNA extraction negative controls) and hypopharyngeal
samples, we separated the hypopharyngeal samples into six
groups based on the amount of DNA measured after DNA
extraction (Extremely low:<0.1 ng/μl, very low: <0.33 ng/μl,
low: <0.8 ng/μl, medium: <1.79 ng/μl, high: <4.58 ng/μl,
very high: ≥4.58 ng/μl). We used analysis of variance,
followed by Tukey multiple comparisons of means to de-
termine which groups were significant different from each
Heapmap of most abundant OTU in Tracheal samples
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other. To create the following heatmap (Fig. 5), we used
the R function “pheatmap” (R-package “pheatmap”) [43].
Statistical analysis
For data treatment and analysis we used the open source
statistical program “R”[44], predominantly the R-package
“phyloseq” [45]. Wilcoxon rank sum test with continuity
correction of difference in core OTUs abundance was
achieved using function “wilcox.test” (R-package “stats”).
Variation in continuous variables between groups was
tested by analysis of variance, using the function “aov”
to create the model, testing the overall variance using
the function “anova” and the variance between individual
groups with the function “TukeyHSD” (all three from R-
package “stats”). For variation in count values of categor-
ical variables (i.e., breastfeeding, antibiotic use, gender)
between groups, we used Pearson’s χ2 test of the signifi-
cance (function “chisq.test,” R-package “stats”). The stat-
istical significance of the difference in distances to each
infant’s own sample and other infant’s samples was
achieved using permutation, by randomly assigning
which column contained the within sample.
Characterization of pneumotypes
Clustering analysis was performed using partitioning
around medoid (PAM) clustering [46]. The Silhouette
index, using both weighted UniFrac distances and
Jensen–Shannon divergence, showed that 5 clusters were
optimal (0.35 and 0.39, respectively) [47]; subsequent
clustering was based on weighted UniFrac distances.
NMDS ordination was performed using the function
“metaMDS” (R-package “vegan” [48]) and the weighted
UniFrac distances. Indicator OTUs were identified
using function “multipatt” (func = “indVal.g,” R-package
“indicspecies” [20]).
Additional files
Additional file 1: Figure S1. Alpha diversity comparison of
hypopharyngeal samples, DNA extraction negative controls, and mock
communities. The four boxplots showing the number of sequencing
reads, the observed richness, the SDI, and the evenness of each
sample. The samples have been separated by type and by concentration of
extracted DNA, for the hypopharyngeal samples. The boxes contain all
samples from the first to third quartile, with a line representing the median
sample, and the hinges extend to the last sample within 1.5 times the
range of the box. Figure S3. Rarefaction curves showed a trend of an
increasing diversity over time. Rarefaction curves were calculated for both
observed richness and SDI, grouped by time-point and with bars indicating
sd. The observed richness did not reach saturation before 15,000 reads,
whereas the SDI reaches a maximum after 1000 reads. Table S1. Alpha
diversity by season. Table S2. Sample overview. Table S3. Most common
OTUs in the core microbiota. Table S4. NMDS coordinates for the six
samples which were excluded from the plots in Fig. 2. Table S5. Indicator
values of the most significant indicator OTUs for each pneumotype.
Table S6. Distribution of samples between the five pneumotypes at each
time-point. Table S7. Number of infants presenting the same pneumotype
continuously. Table S8. Abundance of core microbiota over time. Method
S1. 16S rRNA gene amplification procedure with all details needed for
reproduction. (DOCX 382 kb)
Additional file 2: Figure S2. Relative abundance of hypopharyngeal
microbiota taxa over time. Krona plot showing the overall composition of
the hypopharyngeal microbiota in all samples or at each time-point
separately. This figure is interactive, and in the upper left corner the settings
can be chosen; “Select dataset” to show data for 1 week, 1 month, 3 months,
or all samples. “Max depth” sets to which taxonomic level the data is
aggregated, 1 phylum, 2 class, 3 order, 4 family, 5 genus, 6 OTU.
“Collapse” simplifies the chart by collapsing “redundant” wedges that
are entirely composed of another wedge. “Snapshot” creates an svg
image of the current display, and “Link” creates a link, including the
current customized view. (HTML 403 kb)
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